Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Buscopan for Gastrointestinal Imaging Quality in pCLE
NCT02725398Unknown
- Sponsor
- Xijing Hospital of Digestive Diseases
- Start
- Dec 2013
- Primary completion
- Dec 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of hyoscine butylbromide in gastrointestinal spasm (3 arms), sponsored by Xijing Hospital of Digestive Diseases. Primary endpoint: high quality image ratio up to 3 years. Status: unknown.
02
Drugs
hyoscine butylbromide
03
Conditions
gastrointestinal spasm
Beyond the preview
Go deeper on NCT02725398.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02725398.